AIMS: To evaluate the performance of growth monitoring in detecting diseases. Turner's syndrome (TS) is taken as the target disease. METHODS: Case-control simulation study. Three archetypal screening rules are applied to longitudinal growth data comparing a group with TS versus a reference group from birth to the age of 10 years. Main outcome measures were sensitivity, specificity, and median referral age. RESULTS: Clear differences in performance of the rules were found. The best rule takes parental height into account. Combining rules could improve diagnostic accuracy. CONCLUSION: Growth monitoring is useful to screen for TS. A combined rule that takes absolute height SDS, parental height, and deflection in height velocity into account is the best way to do this. Similar research is needed for other diseases, populations, and ages, and the results should be synthesised into evidence based referral criteria.
AIMS: To evaluate the performance of growth monitoring in detecting diseases. Turner's syndrome (TS) is taken as the target disease. METHODS: Case-control simulation study. Three archetypal screening rules are applied to longitudinal growth data comparing a group with TS versus a reference group from birth to the age of 10 years. Main outcome measures were sensitivity, specificity, and median referral age. RESULTS: Clear differences in performance of the rules were found. The best rule takes parental height into account. Combining rules could improve diagnostic accuracy. CONCLUSION: Growth monitoring is useful to screen for TS. A combined rule that takes absolute height SDS, parental height, and deflection in height velocity into account is the best way to do this. Similar research is needed for other diseases, populations, and ages, and the results should be synthesised into evidence based referral criteria.
Authors: C Rongen-Westerlaken; L Corel; J van den Broeck; G Massa; J Karlberg; K Albertsson-Wikland; R W Naeraa; J M Wit Journal: Acta Paediatr Date: 1997-09 Impact factor: 2.299
Authors: A M Fredriks; S van Buuren; R J Burgmeijer; J F Meulmeester; R J Beuker; E Brugman; M J Roede; S P Verloove-Vanhorick; J M Wit Journal: Pediatr Res Date: 2000-03 Impact factor: 3.756
Authors: A Miranda Fredriks; Stef van Buuren; Minne Fekkes; S Pauline Verloove-Vanhorick; Jan Maarten Wit Journal: Eur J Pediatr Date: 2005-01-21 Impact factor: 3.183
Authors: Gemma White; Shakira Cosier; Afiya Andrews; Lee Martin; Ruben Willemsen; Martin O Savage; Helen L Storr Journal: BMJ Paediatr Open Date: 2022-07
Authors: Paula van Dommelen; Floor K Grote; Wilma Oostdijk; Sabine M P F de Muinck Keizer-Schrama; Bart Boersma; Gerard M Damen; Cassandra G Csizmadia; Paul H Verkerk; Jan M Wit; Stef van Buuren Journal: BMC Pediatr Date: 2008-09-11 Impact factor: 2.125
Authors: Floor K Grote; Wilma Oostdijk; Sabine M P F De Muinck Keizer-Schrama; Friedo W Dekker; Paula van Dommelen; Stef van Buuren; Adry M Lodder-van der Kooij; Paul H Verkerk; Jan Maarten Wit Journal: BMC Public Health Date: 2007-05-11 Impact factor: 3.295
Authors: Floor K Grote; Wilma Oostdijk; Sabine Mpf De Muinck Keizer-Schrama; Paula van Dommelen; Stef van Buuren; Friedo W Dekker; Arnoldus G Ketel; Henriette A Moll; Jan M Wit Journal: BMC Pediatr Date: 2008-05-13 Impact factor: 2.125